GSK-owned ViiV wins FDA label expansion for HIV drug Tivicay for newborns
|
... antiretroviral agents in people older than four
weeks. Its latest approval is supported by data from the IMPAACT 2023 study,
in which HIV-exposed ... |
HIV infections on the rise in Canada despite global decrease
Canada has all the tools it needs to end the HIV epidemic but the country is failing to do so because of a lack of funding, say experts. View article...